Literature DB >> 20807774

Gene expression profiles linked to AT1 angiotensin receptors in the kidney.

Natalia A Makhanova1, Steven D Crowley, Robert C Griffiths, Thomas M Coffman.   

Abstract

To characterize gene expression networks linked to AT(1) angiotensin receptors in the kidney, we carried out genome-wide transcriptional analysis of RNA from kidneys of wild-type (WT) and AT(1A) receptor-deficient mice (KOs) at baseline and after 2 days of angiotensin II infusion (1,000 ng·kg(-1)·min(-1)). At baseline, 405 genes were differentially expressed (>1.5×) between WT and KO kidneys. Of these, >80% were upregulated in the KO group including genes involved in inflammation, oxidative stress, and cell proliferation. After 2 days of angiotensin II infusion in WT mice, expression of ≈805 genes was altered (18% upregulated, 82% repressed). Genes in metabolism and ion transport pathways were upregulated while there was attenuated expression of genes protective against oxidative stress including glutathione synthetase and mitochondrial superoxide dismutase 2. Angiotensin II infusion had little effect on blood pressure in KOs. Nonetheless, expression of >250 genes was altered in kidneys from KO mice during angiotensin II infusion; 14% were upregulated, while 86% were repressed including genes involved in immune responses, angiogenesis, and glutathione metabolism. Between WT and KO kidneys during angiotensin II infusion, 728 genes were differentially expressed; 10% were increased and 90% were decreased in the WT group. Differentially regulated pathways included those involved in ion transport, immune responses, metabolism, apoptosis, cell proliferation, and oxidative stress. This genome-wide assessment should facilitate identification of critical distal pathways linked to blood pressure regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807774      PMCID: PMC3008363          DOI: 10.1152/physiolgenomics.00063.2010

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  41 in total

Review 1.  Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control.

Authors:  E Féraille; A Doucet
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

Review 2.  Role of oxidative stress in angiotensin-induced hypertension.

Authors:  Jane F Reckelhoff; J Carlos Romero
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-04       Impact factor: 3.619

Review 3.  The AT2 receptor--a matter of love and hate.

Authors:  U M Steckelings; E Kaschina; Th Unger
Journal:  Peptides       Date:  2005-04-18       Impact factor: 3.750

4.  Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.

Authors:  V R Holla; F Adas; J D Imig; X Zhao; E Price; N Olsen; W J Kovacs; M A Magnuson; D S Keeney; M D Breyer; J R Falck; M R Waterman; J H Capdevila
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  Tyrosine kinase activation by the angiotensin II receptor in the absence of calcium signaling.

Authors:  T N Doan; M S Ali; K E Bernstein
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

Review 6.  Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase.

Authors:  J H Capdevila; J R Falck; R C Harris
Journal:  J Lipid Res       Date:  2000-02       Impact factor: 5.922

Review 7.  20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.

Authors:  J C McGiff; J Quilley
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-03       Impact factor: 2.894

Review 8.  International union of pharmacology. XXIII. The angiotensin II receptors.

Authors:  M de Gasparo; K J Catt; T Inagami; J W Wright; T Unger
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

Review 9.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

10.  Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease.

Authors:  David G Harrison; Hua Cai; Ulf Landmesser; Kathy K Griendling
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2003-06       Impact factor: 1.636

View more
  7 in total

1.  Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy.

Authors:  Susan B Gurley; Sujoy Ghosh; Stacy A Johnson; Kengo Azushima; Rashidah Binte Sakban; Simi E George; Momoe Maeda; Timothy W Meyer; Thomas M Coffman
Journal:  Diabetes       Date:  2018-07-31       Impact factor: 9.461

Review 2.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

3.  Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC).

Authors:  Ana Konvalinka; Joyce Zhou; Apostolos Dimitromanolakis; Andrei P Drabovich; Fei Fang; Susan Gurley; Thomas Coffman; Rohan John; Shao-Ling Zhang; Eleftherios P Diamandis; James W Scholey
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

4.  Vascular transcriptome profiling identifies Sphingosine kinase 1 as a modulator of angiotensin II-induced vascular dysfunction.

Authors:  Mateusz Siedlinski; Ryszard Nosalski; Piotr Szczepaniak; Agnieszka H Ludwig-Gałęzowska; Tomasz Mikołajczyk; Magdalena Filip; Grzegorz Osmenda; Grzegorz Wilk; Michał Nowak; Paweł Wołkow; Tomasz J Guzik
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

5.  Non-immune Prophylaxis Against COVID-19 by Targeting Tolerance for Angiotensin II-Triggered SARS-CoV-2 Pathogenesis.

Authors:  Michael V Dubina
Journal:  Front Med (Lausanne)       Date:  2022-01-12

6.  Sustained Downregulation of Vascular Smooth Muscle Acta2 After Transient Angiotensin II Infusion: A New Model of "Vascular Memory".

Authors:  Lucie Pothen; Roxane Verdoy; Delphine De Mulder; Hrag Esfahani; Charlotte Farah; Lauriane Y M Michel; Flavia Dei Zotti; Bertrand Bearzatto; Jerome Ambroise; Caroline Bouzin; Chantal Dessy; Jean-Luc Balligand
Journal:  Front Cardiovasc Med       Date:  2022-03-14

7.  Pathogenesis-based preexposure prophylaxis associated with a low risk of SARS-CoV-2 infection in healthcare workers at a designated COVID-19 hospital: a pilot study.

Authors:  Michael V Dubina; Veronika V Gomonova; Anastasia E Taraskina; Natalia V Vasilyeva; Sergey A Sayganov
Journal:  BMC Infect Dis       Date:  2021-06-07       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.